Insider Trading Alert - TNGO, AFSI, VZ, XOM And THC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 19, 2013, 110 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $371.25 to $88,750,792.00.

Highlighted Stocks Traded by Insiders:

Tangoe (TNGO) - FREE Research Report

Gamble Charles D. who is Sr. VP, Customer Account Mgt at Tangoe sold 6,000 shares at $16.18 on Dec. 19, 2013. Following this transaction, the Sr. VP, Customer Account Mgt owned 85,860 shares meaning that the stake was reduced by 6.53% with the 6,000-share transaction.

The shares most recently traded at $17.36, up $1.18, or 6.81% since the insider transaction. Historical insider transactions for Tangoe go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 12,000
  • 24-Week # shares sold: 30,000

The average volume for Tangoe has been 816,700 shares per day over the past 30 days. Tangoe has a market cap of $629.5 million and is part of the technology sector and computer software & services industry. Shares are up 38.5% year-to-date as of the close of trading on Thursday.

Tangoe, Inc. provides communications lifecycle management software and services primarily to commercial enterprises and governmental agencies. The company has a P/E ratio of 149.6. Currently there are 5 analysts that rate Tangoe a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TNGO - FREE

TheStreet Quant Ratings rates Tangoe as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Tangoe Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AmTrust Financial Services (AFSI) - FREE Research Report

Karfunkel George who is Director at AmTrust Financial Services bought 300,000 shares at $28.99 on Dec. 19, 2013. Following this transaction, the Director owned 9.8 million shares meaning that the stake was reduced by 3.17% with the 300,000-share transaction.

Karfunkel Leah who is 10% Owner at AmTrust Financial Services bought 500,000 shares at $30.25 on Dec. 19, 2013. Following this transaction, the 10% Owner owned 10.0 million shares meaning that the stake was reduced by 5.25% with the 500,000-share transaction.

The shares most recently traded at $31.09, up $0.84, or 2.7% since the insider transaction. Historical insider transactions for AmTrust Financial Services go as follows:

  • 4-Week # shares bought: 200,000
  • 12-Week # shares bought: 200,000
  • 12-Week # shares sold: 14,823
  • 24-Week # shares bought: 200,000
  • 24-Week # shares sold: 14,823

The average volume for AmTrust Financial Services has been 784,500 shares per day over the past 30 days. AmTrust Financial Services has a market cap of $2.1 billion and is part of the financial sector and insurance industry. Shares are down 0.24% year-to-date as of the close of trading on Thursday.

AmTrust Financial Services, Inc., through its subsidiaries, underwrites and provides property and casualty insurance in the United States and internationally. The stock currently has a dividend yield of 1.96%. The company has a P/E ratio of 8.0. Currently there are 3 analysts that rate AmTrust Financial Services a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AFSI - FREE

TheStreet Quant Ratings rates AmTrust Financial Services as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, notable return on equity and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full AmTrust Financial Services Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Verizon Communications (VZ) - FREE Research Report

Milch Randal S who is EVP - Pub Policy & Gen Counsel at Verizon Communications sold 2,823 shares at $47.75 on Dec. 19, 2013. Following this transaction, the EVP - Pub Policy & Gen Counsel owned 14,673 shares meaning that the stake was reduced by 16.14% with the 2,823-share transaction.

The shares most recently traded at $48.44, up $0.69, or 1.42% since the insider transaction. Historical insider transactions for Verizon Communications go as follows:

  • 4-Week # shares sold: 2,823
  • 12-Week # shares sold: 2,823
  • 24-Week # shares sold: 2,823

The average volume for Verizon Communications has been 13.1 million shares per day over the past 30 days. Verizon Communications has a market cap of $138.6 billion and is part of the technology sector and telecommunications industry. Shares are up 11.93% year-to-date as of the close of trading on Thursday.

Verizon Communications Inc., through its subsidiaries, provides communications, information and entertainment products and services to consumers, businesses, and governmental agencies worldwide. The stock currently has a dividend yield of 4.37%. The company has a P/E ratio of 63.8. Currently there are 20 analysts that rate Verizon Communications a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VZ - FREE

TheStreet Quant Ratings rates Verizon Communications as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Verizon Communications Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Exxon Mobil Corporation (XOM) - FREE Research Report

Spellings James M Jr who is Vice Pres. & Gen. Tax Counsel at Exxon Mobil Corporation sold 3,995 shares at $97.32 on Dec. 19, 2013. Following this transaction, the Vice Pres. & Gen. Tax Counsel owned 143,350 shares meaning that the stake was reduced by 2.71% with the 3,995-share transaction.

The shares most recently traded at $98.78, up $1.46, or 1.48% since the insider transaction. Historical insider transactions for Exxon Mobil Corporation go as follows:

  • 4-Week # shares sold: 86,314
  • 12-Week # shares sold: 87,766
  • 24-Week # shares sold: 95,428

The average volume for Exxon Mobil Corporation has been 12.8 million shares per day over the past 30 days. Exxon Mobil Corporation has a market cap of $434.8 billion and is part of the basic materials sector and energy industry. Shares are up 14.88% year-to-date as of the close of trading on Thursday.

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas, and manufacture of petroleum products. The company also transports and sells crude oil, natural gas, and petroleum products. It has approximately 37,228 gross and 31,264 net operated wells. The stock currently has a dividend yield of 2.53%. The company has a P/E ratio of 13.0. Currently there are 5 analysts that rate Exxon Mobil Corporation a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XOM - FREE

TheStreet Quant Ratings rates Exxon Mobil Corporation as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Exxon Mobil Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tenet Healthcare (THC) - FREE Research Report

Glenview Capital Management, Llc who is 10% Owner at Tenet Healthcare bought 1.0 million shares at $40.12 on Dec. 19, 2013. Following this transaction, the 10% Owner owned 12.9 million shares meaning that the stake was reduced by 8.39% with the 1.0 million-share transaction.

The shares most recently traded at $39.92, down $0.20, or 0.51% since the insider transaction. Historical insider transactions for Tenet Healthcare go as follows:

  • 4-Week # shares bought: 6,250
  • 12-Week # shares bought: 25,000
  • 12-Week # shares sold: 16,582
  • 24-Week # shares bought: 25,000
  • 24-Week # shares sold: 24,873

The average volume for Tenet Healthcare has been 1.9 million shares per day over the past 30 days. Tenet Healthcare has a market cap of $4.1 billion and is part of the health care sector and health services industry. Shares are up 22.73% year-to-date as of the close of trading on Thursday.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Currently there are 8 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THC - FREE

TheStreet Quant Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and revenue growth. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

NYSE Suspends Trading for Some Shares of Nasdaq-Listed Amazon, Alphabet

NYSE Suspends Trading for Some Shares of Nasdaq-Listed Amazon, Alphabet